Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · IEX Real-Time Price · USD
0.547
-0.003 (-0.51%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Catheter Precision Revenue
In the year 2023, Catheter Precision had annual revenue of $442.00K with 3,057.14% growth. Revenue in the quarter ending December 31, 2023 was $128.00K.
Revenue (ttm)
$442.00K
Revenue Growth
+3,057.14%
P/S Ratio
9.38
Revenue / Employee
$31,571
Employees
14
Market Cap
4.14M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 442.00K | 428.00K | 3,057.14% |
Dec 31, 2022 | 14.00K | -8.00K | -36.36% |
Dec 31, 2021 | 22.00K | -237.00K | -91.51% |
Dec 31, 2020 | 259.00K | -6.94M | -96.40% |
Dec 31, 2019 | 7.20M | 942.00K | 15.06% |
Dec 31, 2018 | 6.26M | 387.00K | 6.59% |
Dec 31, 2017 | 5.87M | -106.00K | -1.77% |
Dec 31, 2016 | 5.98M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Applied DNA Sciences | 9.00M |
ReShape Lifesciences | 8.68M |
Petros Pharmaceuticals | 5.82M |
Helius Medical Technologies | 644.00K |
Aethlon Medical | 574.25K |
VTAK News
- 3 days ago - Catheter Precision, Inc. (VTAK) Announces Receipt of First Purchase Order for LockeT from HCA Healthcare Facility - Accesswire
- 23 days ago - Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year - Accesswire
- 26 days ago - Catheter Precision, Inc. (NYSE American:VTAK) Releases Operational Performance Report, Q4 and Annual 2023 Financials for Year Ending December 31, 2023 - Accesswire
- 5 weeks ago - Catheter Precision, Inc. (NYSE American:VTAK) to Sponsor the Monaco USA Arrhythmia Course - Accesswire
- 6 weeks ago - Catheter Precision, Inc. (NYSE American:VTAK) Announces the First use of VIVO in Qatar - Accesswire
- 6 weeks ago - Catheter Precision, Inc. (NYSE American: VTAK) Announces the First use of LockeT Outside of the United States - Accesswire
- 2 months ago - Catheter Precision, Inc. (NYSE American:VTAK) Announces the First Use of VIVO With a Pediatric Patient in Turkey - Accesswire
- 2 months ago - Catheter Precision, Inc. (NYS American:VTAK) Announces Attendance at the International Symposium on Left Atrial Appendage - Accesswire